3rd September 2020
A new UK study has been launched to assess the impact of COVID-19 on people with cancer. People with cancer are among those at higher risk of COVID-19 complications, as cancer and its treatment can weaken the immune system. The Clinical Characterisation Protocol (CCP) CANCER-UK project will run over 12 months and will examine questions that are important for the care of patients with cancer.